Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allumia Ventures is an independent healthcare-focused venture capital firm investing in commercial-stage companies leveraging technology to address major challenges in healthcare. It was spun out from Providence Ventures and remains anchored by Providence as its lead limited partner. The firm focuses on digital health, tech-enabled healthcare services, and medtech startups[1][2][4].
Since inception (originally as Providence Ventures), the team has backed 29 companies with 10 successful exits. Their portfolio spans providers, payors, employers, pharma stakeholders and patients[2][4]. They emphasize partnerships that drive adoption across the healthcare ecosystem.
The firm does not develop drugs or devices itself but invests in companies that do.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allumia Ventures.